What question did this study set out to answer?

To assess how male sex influences survival and the risk of developing haematological malignancies in MGUS patients.

February 2, 2026HaematologicaOpen Access

Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study

View Full Paper

Ask AI

Bookmark

To assess how male sex influences survival and the risk of developing haematological malignancies in MGUS patients.
Analyzed a UK population-based cohort of 4651 MGUS patients from 2005 to 2019
Evaluated patient and disease characteristics alongside survival rates
Compared malignancy incidence rates between males and females
5-year net survival for MGUS patients was 87.8%
Survival rate for males was 83.8%, while females had a survival rate of 92.2%
Males had a higher rate of subsequent haematological malignancies (8.8%) compared to females (5.3%)

No takes yet. Share an insight, caveat, or question.

Population-based analysis reveals reduced survival and increased malignancy risk for males with MGUS, indicating a gender disparity in outcomes.

Roman et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Population-based analysis reveals reduced survival and increased malignancy risk for males with MGUS, indicating a gender disparity in outcomes.